Profil Institute Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

Profil Institute Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

SAN DIEGO, October 13, 2015 – Profil Institute for Clinical Research, a clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, celebrates its 11th year as a corporate sponsor of San Diego’s Step Out: Walk to Stop Diabetes, hosted by the American Diabetes Association (ADA).  The company’s fundraising to benefit the ADA this year, including the Step Out Walk and the Tour de Cure, comes to more than $40,000.

“Profil Institute is a supporter of the American Diabetes Association in every manner possible. We have the common goal of advancing research and finding better treatments to eradicate diabetes,” said Dr. Marcus Hompesch, Profil Institute President and CEO. “The Step Out Walk is our opportunity to sponsor and volunteer for an event benefiting the American Diabetes Association while walking side by side with the very people for whom our clinical research will hopefully make a significant impact.”

The Step Out Walk in San Diego will take place this Sunday, October 18 at NTC Park in Liberty Station.

About Profil Institute for Clinical Research, Inc.
Profil Institute is an early engagement clinical research organization (CRO) exclusively focused on metabolic diseases, including diabetes, obesity and NAFLD/NASH. The company is recognized globally for its scientific expertise, expanded scope of research methodologies, and experience with every clinically relevant drug class in diabetes. Profil Institute provides a full scope of CRO services from consulting for strategic clinical development and regulatory planning through design and completion of complex clinical trials, including the reporting and publication of final study results.

Profil Institute’s expertise and experience encompasses small and large molecule therapies, biologics and biosimilars through all routes of administration, as well as devices. The company’s clients range from large pharma and drug discovery companies to small virtual companies throughout the Americas, Europe and Asia.

Profil Institute is also widely recognized as an innovator of methodologies, including its Automated Glucose Clamp technology, and for driving new, higher standards in metabolic clinical research through collaborative science with key academic and industry partners. For more information, visit www.profilinstitute.com.

For further information, please contact:
Abby Devine
Profil Institute for Clinical Research, Inc.
Corporate Communications
abby.devine@profilinstitute.com
+1 (858) 663-6148